Ebola East DRC August 2018 (360G-Wellcome-214626_Z_18_Z)
The goal of this submission is to provide immediate support to the Institut Nationale De Recherche Biomedicale (INRB) for the implementation of Monitored Emergency Use of MAb114 during the ongoing Ebola Virus Disease (EVD) outbreak in Eastern DRC, and to strengthen capacity to implement a formal clinical trial of candidate therapeutics, as identified as a priority in the national EVD research plan. Support is requested for INRB administration, logistics, consumables and personal costs, and for training and capacity development activities.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 87472 |
| Applicant Surname | Horby |
| Approval Committee | Internal Decision Panel |
| Award Date | 2018-09-30T00:00:00+00:00 |
| Financial Year | 2017/18 |
| Grant Programme: Title | DFID-Wellcome Epidemic Preparedness Grant |
| Internal ID | 214626/Z/18/Z |
| Lead Applicant | Prof Peter Horby |
| Other Applicant(s) | Prof Jean-Jacques Muyembe-Tamfum |
| Partnership Name | Wellcome-DFID Epidemic Response |
| Partnership Value | 174946 |
| Planned Dates: End Date | 2021-04-01T00:00:00+00:00 |
| Planned Dates: Start Date | 2018-10-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | South East |